about
Informatics and standards for nanomedicine technologyIn Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles.Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectivesBiomedical applications of multifunctional plasmonic nanoparticles.Product quality for nanomaterials: current U.S. experience and perspective.Nanomaterials-based biosensors for detection of microorganisms and microbial toxins.Gd(3+)-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent.
P2860
Q23912034-3B7EBB02-AA13-440A-B201-F6C7D5048684Q26779017-4FAE59C7-D92E-44CC-8967-F7DFCD6BF2B4Q28818039-10310160-F53E-4134-8EBE-80242E207470Q38034178-907A604C-E542-4339-8EFB-C75853738818Q38340318-568E5B0F-A3E6-40C9-ADEB-45D6C2BBD9DAQ38992701-1625E315-B7A5-4F86-B71B-31C9ACC1C82DQ39540783-4A3453BF-C6B2-49F1-8C6F-42BD6FAC8D29
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Commercialization of nanotechnology.
@en
Commercialization of nanotechnology.
@nl
type
label
Commercialization of nanotechnology.
@en
Commercialization of nanotechnology.
@nl
prefLabel
Commercialization of nanotechnology.
@en
Commercialization of nanotechnology.
@nl
P2860
P356
P1476
Commercialization of nanotechnology.
@en
P2093
David W Hobson
P2860
P304
P356
10.1002/WNAN.28
P577
2009-03-01T00:00:00Z